Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Rackspace Technology Inc. Common Stock (RXT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Rackspace Technology Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Rackspace Technology Inc. Common Stock trades at $3.11 (market cap $925.19M). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 9.6× Rackspace Technology Inc. Common Stock's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Rackspace Technology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Rackspace Technology Inc. Common Stock for 0 Days on average.
| KYMR | RXT | |
|---|---|---|
Market Cap | $8.87B | $925.19M |
Volume | 779,107 | 2,631,364 |
Sector | Health | Technology |
52-Week High | $127.31 | $7.53 |
52-Week Low | $55.80 | $0.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $4.09B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Rackspace Technology Inc. Common Stock
Rackspace Technology, Inc. provides managed multicloud and hybrid cloud services, helping organizations design, operate, and support workloads across AWS, Microsoft Azure, Google Cloud, and private infrastructure.
Read more on RXT →
